Indication
Visceral Leishmaniasis
4 clinical trials
7 products
Clinical trial
An Open Label, Phase III, Randomized Controlled, Multicentre Non-Inferiority Trial to Compare Efficacy and Safety of Miltefosine and Paromomycin With SSG and PM Combination for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern AfricaStatus: Completed, Estimated PCD: 2020-12-11
Product
MiltefosineProduct
ParomomycinProduct
Sodium stibogluconateClinical trial
A Phase II, Multicentre, Randomized, Two-arm Blinded Study to Assess the Efficacy and Safety of Two LXE408 Regimens for Treatment of Patients With Primary Visceral LeishmaniasisStatus: Recruiting, Estimated PCD: 2025-01-02
Product
LXE408Product
AmBisome®Clinical trial
A Randomized, Open-label, Phase II, Single-centre Study to Evaluate the Efficacy, Safety and Pharmacokinetics of LXE408 in Patients With Primary Visceral Leishmaniasis in EthiopiaStatus: Recruiting, Estimated PCD: 2025-06-30
Product
Sodium StibogluconateClinical trial
A Multicentre Observational Study to Assess Immune Response Status in Patients Before and After Treatment for Visceral LeishmaniasisStatus: Recruiting, Estimated PCD: 2024-11-01